Archive for April, 2007

Inspire Announces FDA Approval Of AzaSite - dBusinessNews Triangle (press release)

Inspire Announces FDA Approval Of AzaSitedBusinessNews Triangle (press release), NC - 1 hour agoAzithromycin is a semi-synthetic antibiotic that is derived from erythromycin and has been available in an oral form under the trade name Zithromax ® by …

Read full story

Comments

Inspire Announces FDA Approval Of AzaSite ™ - Business Wire (press release)

Inspire Announces FDA Approval Of AzaSite ™Business Wire (press release), CA - 12 hours agoAzithromycin is a semi-synthetic antibiotic that is derived from erythromycin and has been available in an oral form under the trade name Zithromax ® by …

Read full story

Comments

Pfizer Earnings Fall on Drop in Norvasc, Zoloft Sales (Update5) - Bloomberg

Pfizer Earnings Fall on Drop in Norvasc, Zoloft Sales (Update5)Bloomberg - Apr 20, 2007Those medicines include Norvasc, Zoloft and the antibiotic Zithromax. When a drug's patent expires, cheaper copies are marketed, driving prices down as much …

Read full story

Comments

Pfizer's profit drops on charges - MarketWatch

Pfizer's profit drops on chargesMarketWatch - Apr 20, 2007Pfizer's revenue stream has been evaporating in recent quarters due to the expiration of patents on such once-hot drugs as Zoloft, Zithromax and, …

Read full story

Comments

Pfizer's Q1 profit drops 17% on charges - St. Louis Business Journal

Pfizer's Q1 profit drops 17% on chargesSt. Louis Business Journal, MO - Apr 20, 2007The products and losses include Norvasc (down $115 million), Zoloft (down $615 million) and Zithromax (down $112 million). For the first quarter ended April …

Read full story

Comments

Pfizer's earnings fall - CNNMoney.com

CNNMoney.comPfizer's earnings fallCNNMoney.com - Apr 20, 2007Company sales growth has also stalled due to generic competition for other former big sellers, including antibiotic Zithromax and anti-depressant Zoloft. …

Read full story

Comments

Analysis: Pfizer solid despite earns dip - United Press International

Analysis: Pfizer solid despite earns dipUnited Press International - Apr 20, 2007Zoloft sales at $146 million were down $615 million, and Zithromax sales at $131 million were down $112 million.

Read full story

Comments

Pfizer's Q1 profit drops 17% on charges - Milwaukee Business Journal

Pfizer's Q1 profit drops 17% on chargesMilwaukee Business Journal, WI - 3 hours agoThe products and losses include Norvasc (down $115 million), Zoloft (down $615 million) and Zithromax (down $112 million). For the first quarter ended April …

Read full story

Comments

Charges Drag Pfizer Q1 Profit Down 18%; Adj. Profit Up 10%; Cuts … - Trading Markets

Canada.comCharges Drag Pfizer Q1 Profit Down 18%; Adj. Profit Up 10%; Cuts …Trading Markets, CA - Apr 20, 2007Norvasc sales decreased 10% to $1.06 billion, sales of Zoloft plunged 81% to $146 million and Zithromax dropped 49% to $131 million. …Pfizer's earnings fall CNNMoney.comall 298 news articles

Read full story

Comments

Pfizer's Q1 profit drops 17% on charges - Washington Business Journal

Pfizer's Q1 profit drops 17% on chargesWashington Business Journal, DC - 13 hours agoThe products and losses include Norvasc (down $115 million), Zoloft (down $615 million) and Zithromax (down $112 million). For the first quarter ended April …

Read full story

Comments

· « Previous entries